Shanghai Kaibao Pharmaceutical Co., Ltd.

(Summary description)Shanghai Kaibao Pharmaceutical Co., Ltd. was incorporated in the Gulf Tourist Area on April 12, 2000. The leading product of Kaibao Pharmaceutical with independent intellectual property rights is the national second-class new drug Tanreqing Injection, which was authorized by the State Intellectual Property Office on December 15, 2000, with the patent number of ZL94103391.0. This medicine is the first batch of traditional Chinese medicine injections in my country that are tested and produced according to the "Chinese Pharmacopoeia" fingerprint. The injection has achieved new results in terms of efficacy, safety and stability of antipyretic, expectorant, anti-inflammatory and antiviral. Breakthrough, in 2008, sales accounted for 22.2% of the national heat-clearing and detoxifying injections.

Shanghai Kaibao Pharmaceutical Co., Ltd.

(Summary description)Shanghai Kaibao Pharmaceutical Co., Ltd. was incorporated in the Gulf Tourist Area on April 12, 2000. The leading product of Kaibao Pharmaceutical with independent intellectual property rights is the national second-class new drug Tanreqing Injection, which was authorized by the State Intellectual Property Office on December 15, 2000, with the patent number of ZL94103391.0. This medicine is the first batch of traditional Chinese medicine injections in my country that are tested and produced according to the "Chinese Pharmacopoeia" fingerprint. The injection has achieved new results in terms of efficacy, safety and stability of antipyretic, expectorant, anti-inflammatory and antiviral. Breakthrough, in 2008, sales accounted for 22.2% of the national heat-clearing and detoxifying injections.

Categories:Client Case
Author:
Origin:
Time of issue:2017-10-13 13:03
Views:

Shanghai Kaibao Pharmaceutical Co., Ltd. was incorporated in the Gulf Tourist Area on April 12, 2000. The leading product of Kaibao Pharmaceutical with independent intellectual property rights is the national second-class new drug Tanreqing Injection, which was authorized by the State Intellectual Property Office on December 15, 2000, with the patent number of ZL94103391.0. This medicine is the first batch of traditional Chinese medicine injections in my country that are tested and produced according to the "Chinese Pharmacopoeia" fingerprint. The injection has achieved new results in terms of efficacy, safety and stability of antipyretic, expectorant, anti-inflammatory and antiviral. Breakthrough, in 2008, sales accounted for 22.2% of the national heat-clearing and detoxifying injections.

Previous: None

Next: Shanghai Best Electric Co., Ltd.

Previous: None

Next: Shanghai Best Electric Co., Ltd.